Search
Searching Content by Matthew Tabas ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
US Antitrust Year In Review: The Trump Administration's Second Year
Partners from our global Antitrust/Competition team review key 2018 developments in US antitrust law and provide an assessment of enforcement policy during the second year of the Trump Administration.
United States
21 Jan 2019
2
FTC Comment On FDA's Guidance On Citizen Petition Process Underscores Antitrust Risk
On December 4, 2018, the US Federal Trade Commission released a comment responding to the Food and Drug Administration's October 2, 2018 revised draft guidance titled Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) ...
United States
12 Dec 2018
3
Global Overview
Once again this year, much of the activity at the intersection of antitrust and intellectual property law has revolved around the issue of industry standards
Worldwide
29 Oct 2018
4
FDA's Revised Draft Guidance On Citizen Petition Process Highlights Antitrust Risk For Filers
On October 2, 2018, the Food & Drug Administration released revised draft guidance regarding Citizen Petitions and Petitions for Stay of Action under Section 505(q) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
United States
18 Oct 2018
5
Competition Among Biologic Products: A Renewed US Government Focus Suggests Biologics Manufacturers Should Expect Antitrust Scrutiny
US antitrust authorities and Congress have long been concerned with promoting competition in the pharmaceutical industry.
United States
19 Sep 2018
6
FTC Workshop Signals Continued Focus on Prescription Drug Competition
The FTC's stated purpose for its workshop was to study the barriers to generic drug competition and whether other market forces create inefficiencies that lead to higher drug prices.
United States
17 Nov 2017
7
FTC Merger Remedy Study: Key Takeaways
On February 3, 2017, the US Federal Trade Commission released the findings of its "Merger Remedy Study" which examined the effectiveness of Commission-required remedies in transactions from 2006 to 2012.
United States
9 Feb 2017
8
More On Physicians And Antitrust Laws
From international law firm Arnold & Porter Kaye Scholer LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today's physicians and health care executives.
United States
6 Feb 2017
9
Mallinckrodt Pays $100 Million In One Of FTC's Last Antitrust Actions Of The Obama Administration
On January 18, 2017, the U.S. Federal Trade Commission and the Attorneys General of Alaska, Maryland, New York, Texas, and Washington filed a complaint in federal district court for the District of Columbia . . .
United States
30 Jan 2017
Links to Result pages
 
1